Sets key financial goal as return on capital employed of around 11 percent by 2027
trinamiX showcase its mobile solution for reliable textile identification, including the new handheld spectrometer trinamiX PAL Two
For FY25, Grasim's consolidated Revenue reached an all-time high of Rs. 1,48,478 crore
The global alignment of Univar Solutions and Shandong Head Group focuses on sustainability, quality, and innovation in advancing pharmaceutical formulations with high quality excipients in drug delivery systems
The new E-GRADE unit will bolster Huntsman's portfolio by providing high-purity, low-trace metal amines, including quaternary amines and amine oxides, essential for semiconductor chip manufacturing.
The intended closures follow last year's announcements regarding three manufacturing sites located in Europe and Africa
PAT in FY24-25 stood at Rs. 573 crore as compared to Rs. 524 crore in FY23-24
New product complements portfolio of sustainability advantaged powder coatings
Strong growth driven by high-margin lubricants, EPC, and waste management businesses
The company posted net profit of Rs. 36,225.61 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 6,550.93 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 359.85 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs .26.80 crores for the Financial Year ended March 31, 2025
IBC is a leading innovator in prismatic cell technologies designed for energy storage and mobility applications across global markets
New model-based platform designed to accelerate process development of active pharmaceutical ingredients
Technology is potentially a flexible and cost-effective energy solution for a variety of industrial applications
BASF is relocating its Global R&D leaching activities from Tucson, Arizona, to its state-of-the-art R&D facility in Houston, Texas
ECHA’s redesigned C&L Inventory is now available in the Agency’s new chemicals database, ECHA CHEM
His current term will therefore conclude as scheduled on August 31, 2026
Symrise has argued strongly from the outset that it should never have been part of this investigation
Subscribe to our newsletter & stay updated.
